Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Eaton

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical and Translational Gastroenterology|April 1, 2016
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's DiseaseMichael Epstein, David A Johnson, Robert Hawes, et al.
Neurology and Therapy|December 22, 2021
Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched ControlsEmma Viscidi, Maneesh Juneja, Jin Wang, et al.
Neurology and Therapy|May 4, 2022
Correction to: Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched ControlsEmma Viscidi, Maneesh Juneja, Jin Wang, et al.
Movement Disorders Clinical Practice|December 16, 2017
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's DiseaseDavid G Standaert, Ramon L Rodriguez, John T Slevin, et al.
NPJ Parkinson'S Disease|July 21, 2017
Efficacy and safety of levodopa-carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson's disease patientsMiho Murata, Masahito Mihara, Kazuko Hasegawa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2018
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's diseaseHubert H Fernandez, James T Boyd, Victor S C Fung, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2015
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trialsAnthony E Lang, Ramon L Rodriguez, James T Boyd, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical and Translational Gastroenterology|April 1, 2016
Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's DiseaseMichael Epstein, David A Johnson, Robert Hawes, et al.
Neurology and Therapy|December 22, 2021
Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched ControlsEmma Viscidi, Maneesh Juneja, Jin Wang, et al.
Neurology and Therapy|May 4, 2022
Correction to: Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched ControlsEmma Viscidi, Maneesh Juneja, Jin Wang, et al.
Movement Disorders Clinical Practice|December 16, 2017
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's DiseaseDavid G Standaert, Ramon L Rodriguez, John T Slevin, et al.
NPJ Parkinson'S Disease|July 21, 2017
Efficacy and safety of levodopa-carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson's disease patientsMiho Murata, Masahito Mihara, Kazuko Hasegawa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2018
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's diseaseHubert H Fernandez, James T Boyd, Victor S C Fung, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2015
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trialsAnthony E Lang, Ramon L Rodriguez, James T Boyd, et al.
Pageof 3